Daniel Burnett, MD, MBA

Entrepreneur-In-Residence, UCSF-STanford Pediatric Device Consortium
President & CEO, TheraNova

The PDC’s business planning advising will be led by Entrepreneur-in-Residence, Dan Burnett. He is President and CEO of the San Francisco medical device incubator Theranova, LLC, and has a long history of biomedical device design and testing.

After graduating from University of Pennsylvania’s School of Bioengineering, Dr. Burnett spent a year at the FDA testing devices and writing congressional reports on the current state-of-the-art devices. Following receipt of his MD and MBA degrees from Duke University, Dr. Burnett completed his one-year internship at the Mayo Clinic in Jacksonville, Florida and is a licensed physician in the state of California.

After working as a general partner with MedVenture Associates, a medical device venture capital form in Emeryville, CA, Dr. Burnett launched TheraNova. Since 2006, TheraNova has incubated 12 companies and raised over $280M in venture capital and $13M in grant funding. THey hold 51 issued patents and currently have two products on the market, including their sensor-enabled urinary catheter Accuryn Monitoring System, which received FDA 510(k) clearance in 2016.